Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.

Autor: Zhang, Yuyuan1 (AUTHOR), Xu, Mengjun2 (AUTHOR), Ren, Yuqing3 (AUTHOR), Ba, Yuhao1 (AUTHOR), Liu, Shutong1 (AUTHOR), Zuo, Anning1 (AUTHOR), Xu, Hui1 (AUTHOR), Weng, Siyuan1 (AUTHOR), Han, Xinwei1,4,5 (AUTHOR) fcchanxw@zzu.edu.cn, Liu, Zaoqu1,4,5,6 (AUTHOR) liuzaoqu@163.com
Zdroj: Molecular Cancer. 4/6/2024, Vol. 23 Issue 1, p1-20. 20p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje